Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0000899866-20-000090)

Filing Details

Accession Number:
0000899866-20-000090
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-04 16:47:49
Reporting Period:
2020-12-02
Accepted Time:
2020-12-04 16:47:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899866 Alexion Pharmaceuticals Inc. ALXN Pharmaceutical Preparations (2834) 133648318
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1792124 Tanisha Carino C/O Alexion Pharmaceuticals, Inc.
121 Seaport Boulevard
Boston MA 02210		 Evp & Ccao No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Per Share Disposition 2020-12-02 665 $121.76 17,632 No 4 F Direct
Common Stock, Par Value $.0001 Per Share Disposition 2020-12-03 1,530 $122.26 16,102 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
  2. This sale was made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.